South Africans can now buy weight-loss drugs and ‘pay later’
The cost of GLP-1s could come down Obesity and being overweight are not prescribed minimum benefits (PMBs) that medical schemes are required to cover, so schemes are not obliged to pay for GLP-1s used for weight loss from their risk benefits.
Buy now, pay later (BNPL) products, which offer interest-free credit, can now be used to pay for weight-loss drugs.
The programme pairs low-dose GLP-1 treatment with structured coaching, targeting up to 10% body weight loss over six months with lower doses being more affordable, but usually leading to slower weight loss.
This is a summary of the original articles listed below. Always read the source articles for the full context. GhanaSummary does not create or modify the news — we summarise and link to original publishers.
